Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

An open label, repeat dose, dose escalation study conducted in Parkinson's Disease patients to characterize the pharmacokinetics and effect of food on ropinirole prolonged release (PR/CR) 12mg tablets.
ropinirole
ROP109087
NCT00460148
Parkinson Disease
Phase 2
 
May 2013

Powered by ideaPoint, Inc.